TCL Archive FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment. March 31, 2000
TCL Archive ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay July 17, 2009